跳至主要内容
临床试验/NCT00504088
NCT00504088终止4 期

Plaque Removal Versus Open Bypass Surgery For Critical Limb Ischemia

FoxHollow Technologies31 个研究点 分布在 1 个国家开始时间: 2006年10月1日最近更新:
适应症

试验速览

阶段
4 期
状态
终止
发起方
试验地点
31
主要终点
Major amputation-free survival

研究概览

简要总结

To compare the outcome of bypass surgery and plaque excision for treatment of critical limb ischemia in the lower limbs

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Ischemic rest pain for more than 2 weeks or ulceration or gangrene of the foot or toes (Rutherford Becker Category 4, 5 or 6)
  • •Willing and able, as evaluated by the PI, to provide Informed Consent
  • •Willing to undergo up to 5 years of clinical follow up visits as scheduled
  • •Angiographic pattern of infrainguinal disease that can be reasonably managed either by surgery or plaque excision in the first instance
  • •Reconstitution of at least one patent target tibial segment below the knee which provides run-off to the foot
  • •The patient must be >18 years of age
  • •Target lesion(s) is located at or below the level of the superficial femoral artery
  • •Target lesion(s) is >50% stenosed by quantitative vascular angiography
  • •Ability to take at least one of the following types of medications: anti- platelet or anti-thrombotic therapy

排除标准

  • •Patient has cardiac or cardiovascular comorbidities that would make surgery inappropriate
  • •Patient has terminal or Stage 4 cancer
  • •Patient has extensive gangrene that requires both a Below-the-Knee amputation and a revascularization procedure
  • •Previous stent in the target lesion
  • •Active infection at planned incision site
  • •The patient is a pregnant woman
  • •The patient has significant suprainguinal or Common Femoral disease that can not be treated either prior to or during the index procedure
  • •Target Lesion is a Chronic Total Occlusion (CTO) that is greater than 15cm in length and has severe, continuous calcification

结局指标

主要结局

Major amputation-free survival

次要结局

未报告次要终点

研究者

发起方
FoxHollow Technologies
申办方类型
Industry

研究点 (31)

Loading locations...

相似试验